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ABSTRACT
EFFECTS OF SURFACE-ACTIVE AGENTS ON THE 
SUSCEPTIBILITY OF SWISS MICE TO CANDIDA ALBICANS
Harvey W. Holm, Master of Science
The thesis here abstracted was written under the 
direction of Dr. Richard M. Marwln and approved by Dr. 
Robert G. Fischer and Dr. Jerald L. Connelly as members 
of the examlng committee of which Or. Marwln was Chair­
man.
White Swiss mice are generally resistant to Can­
dida albicans injected 1ntraper1tonea11y. An effort 
was made to determine 1f surfactants when combined with 
Candida albicans would decrease the LD50 of this organism. 
The surfactants tested were Plurafac B26, Polyethylene 
Glycol 1*00 Mono Laurate, Mulsor 22k, and Pluronlc L62.
Peritoneal leukocyte and differential counts, 
tissue sections, and blood cultures were done to deter­
mine the action of surfactants.
The following conclusions were made:
(a) Plurafac B26, Polyethylene Glycol 1*00 Mono 
Laurate, Pluronlc L62, and Mulsor 221* in­
crease mouse susceptibility to Candida al-
bicans,
(b) The degree of susceptibility enhancement 
varies among the surfactants tested.
(c) Plurafac B26 Initially destroys leukocytes 
in the peritoneal cavity.
(d) Massive Invasion of the pancreas may be the 
cause of death of animals given a Candida 
albicans - surfactant combination 1ntra- 
perttoneal1y.
The results suggest that surfactants may be a
diagnostic tool of value 1n enhancing mouse suscepti­
bility to Candida albicans.
This abstract of a thesis submitted by Harvey 
W. Holm In partial fulfillment of the requirements for the 
Degree of Master of Science 1n the University of North 
Dakota, 1s hereby approved by the Committee under whom the 
work has been done.
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EFFECTS OF SURFACE-ACTIVE AGENTS ON THE SUSCEPTIBILITY
OF SWISS MICE TO CANOIDA ALBICANS
INTRODUCTION
Susceptibility of Laboratory Animals to Candida albicans
The laboratory mouse Is commonly the animal of 
choice for pathogenic and therapeutic studies. If the 
mouse responds equally as favorably as other laboratory 
animals 1n a given situation, 1t 1s generally used. The 
size of the mouse dictates Its use because of space, ex­
pense, and availability factors. However, there are in­
stances when the laboratory mouse 1s not as susceptible 
to an Infectious organism as another laboratory animal. 
Early studies by Benham In 1931 showed that the rabbit 
was readily susceptible to Candida albicans while the 
mouse was considered resistant (1). She Injected Candida 
albicans microorganisms Intravenously into rabbits; death 
occurred with In four or five days. Stovall and Pessln, 
in a paper published In 1931*. observed that Candida 
albicans produced death or extensive lesions when 0.5 - 
1.5 million cells/100 grams of body weight were Injected 
Intravenously Into rabbits, but other species of Candida 
required many more organisms per 100 grams of body weight 
to cause Injury or death (2).
In 1951 Fuentes et a U  studied the pathogenicity
-1-
-2-
of Candida albicans In laboratory animals (3). One mil­
lion mlcroorganlsms/100 grams of body weight were Injected 
Intravenously Into rats, mice, rabbits, and guinea pigs. 
The most susceptible animal appeared to be the rat, fol­
lowed by the rabbit, the guinea pig, and the mouse. The 
average survival time was 5 days for rats and rabbits,
11 days for guinea pigs, and 15 days for mice.
Later papers demonstrated that mice were suscept­
ible to Candida albicans. In 195^# Solotorovsky showed 
that white Swiss laboratory mice were susceptible to 
Candida albicans given Intravenously (4). A later work 
by Mankowskl reported that 4 X 10^ Candida albicans 
organisms Injected Intravenously killed nearly all of the 
mice Injected within 3 days, whereas the same number of 
Candida albicans organisms Injected intraperitoneal1y 
were generally non-pathogen1c for white Swiss mice (5)»
He also observed that other species of Candida were 
usually less pathogenic than Candida albicans.
Hasenclever, through h1s extensive study made In 
1959* reported that the relative susceptibility of mice 
and rabbits to candidiasis was about equal (6). The 
number of organisms received by each animal Intravenously
was dependent upon the weight of the animal. Hasenclever 
stated that the reason rabbits were previously considered 
susceptible to Candida albicans, and mice were not, was 
that In the original work rabbits were Injected Intra­
venously and mice were Injected Intraperltoneally. This 
work also showed that pathogenicity varied with each 
strain of Candida albicans.
Candida albicans organisms have also been Injected 
Intravenously Into guinea pigs. Winner, 1n I960, found 
that guinea pigs Infect with Candida albicans died as 
a result of acute pulmonary changes (7)» No study of 
comparative pathogenicity of Candida albicans for mice 
and guinea pigs was made.
Generally, there Is a lack of Information of path­
ogenicity of Candida albicans for laboratory animals. No 
extensive work with LDSO's has been done.
Attempts to Increase Mouse Susceptibility to Candida albicans
Although Hasenclever showed that under proper 
conditions the Swiss mouse and the rabbit were equally 
susceptible to Candida albicans Injected Intravenously, 
a large number of organisms was a prerequisite of Infection 
(8). The Ideal situation would be to have a lowered LD50 
of Candida- alfalcanr when Injected 1ntraper1 toneally. (The
- 3-
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1ntraper1toneal Injection 1s generally favored by labor­
atory personnel because of the simplicity of execution).
One of the Initial substances used to Increase 
the susceptibility of mice to Infectious agents was mucin. 
Mankowskl showed that the virulence-enhancing power of 
mucin greatly decreases as the percentage of mucin was 
lowered from 10 per cent to 1.5 per cent (9). He sug­
gested using a 5 per cent mucin solution for maximum 
efficiency.
In 1951 Salvln et a K  reported on the use of 2.5 
per cent gastric mucin to produce high rates of Infection 
and mortality In white Swiss mice Injected with Candida 
al bicans (10). This work showed that the Intracerebral 
route of Injection was the most effective, and the sub­
cutaneous route was the least effective. The Intraperl- 
toneal route was Intermediate in Its effect. Strauss 
and Kllgman, who also showed that gastric mucin lowered 
the resistance of mice to Candida albicans, suggested 
that gastric mucin might be of great value In the study 
of deep-seated mycoses (1 1 ).
Certain antibiotics have also been used to Increase 
animal susceptibility to fungus Infections. Sellgmann, In
•v
1953» found that Candida albicans mixed with either aureo-
*5
mycln or terramycln produced Increased fatalities In mice 
(12). Others confirmed this work (13).
Another substance, cortisone, has been shown to 
Increase the susceptibility of mice to Candida albicans. 
Sellgmann showed that Intraperltoneal Injections of corti­
sone Increased the death rate when mice were challenged 
with Candida albicans (14). A11 other routes of administra­
tion with cortisone did not Increase mouse susceptibility. 
Lour la et a_[. In I960, also showed that cortisone Increased 
the rate of Infection In mice by Candida albicans (15).
In 1957 Roth et a K  found that pre-treatment of 
mice with roentgen radiation and cortisone, given either 
singly or In combination, reduced resistance to Candida 
albicans (16). They explained the action of radiation 
as one or a combination of the following* (a) Inhlblton 
of the Inflammatory resonse, (b) Inhlblton of the Immune 
response, (c) Impairment of the retlculo-endothel1a 1 system, 
or (d) a direct effect upon the Invading pathogen. They 
suggested that cortisone Inhibited the Inflammatory response. 
Surface-Active Agents
Another special group of compounds has been found 
to have varied effects on biological systems. These com­
pounds are known as surface-active agents, surfactants, 
detergents, syndets, surface tension depressants, or wet-
- 6-
t1ng agents. Schwartz (17) characterized these compounds
In the following manner:
“Certain solutes, even when present In 
very low concentration, have the start*
1 1ng property of altering the surface 
energy of their solvents to an extreme 
degree. The effect Is Invariably a 
lowering rather than an increase of the 
surface energy. Solutes having such 
properties have come to be known as the 
surface-active agents, snd their unusual 
effect 1s known as surface activity."
Surfactant molecules are composed of two portions:
a non-polar end that 1s not soluble In water (hydrophobic),
and a polar end that 1s soluble in water (hydrophl1 1 c) (18).
The non-polar portions of the molecule may be straight,
branched, or cyclic saturated hydrocarbons; or they may
be aromatic hydrocarbons such as benzene and napthalene (19).
The hydrophilic portion of the surfactant molecule
may be either Ionic or non-ionic. The active groups of
Ionic detergents may be anionic (-COO" -0S020“ or -S020-)
or they may be cationic (-N(CH^)^+) (20). Non-1on1c
detergents have non-1on1zab1e high affinity end groups
usually containing oxygen, nitrogen, or sulfur atoms in
non-ionizing configurations. Generally, it 1s unusual
to have non-1on1c substances other than hydroxyl and
ether groups occurring In sufficient numbers to make the
molecule soluble In water (2 1).
- 7-
Modern synthetic methods allow the Introduction of 
controlled numbers of ether or hydroxyl molecules into a 
hydrophobic molecule. An example showing how to produce 
ionic surface-active agents is as follows: A hydrophobic 
hydroxyl compound (phenol or alcohol) combines with 
several moles of ethylene oxide or propylene oxide (22).
The number of ethylene oxide groups needed depends on the 
molecular weight of the hydrophobic portion of the molecule 
(23).
The Role of Surface-Active Agents in Biology
Surfactants have been found to have diversified 
applications to microbiology. Some of the properties of 
certain surfactants are as follows:
(a) Surfactants Increase the rate of growth
of certain bacteria In culture media (2^, 25).
(b) Surfactants Inhibit bacterial growth (26, 27).
(c) Surfactants clear (semi-digest) scales, 
hair, and nail scrapings to aid identifi­
cation of fungi by slide preparations (28).
(d) Surfactants Inhibit bacterial metabolism (29, 30).
R-OH ♦ CH„ CH2---------> R-O-C2HI+-OH
Moderate heat
Moderate pressure — Conditions 
Alkaline catalyst
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(e) Surfactants increase the actions of bactericidal 
substances (3 1).
(f) Surfactants increase the rate of growth of 
fungi In culture media (32, 33).
(g) Surfactants Increase the susceptibility of 
laboratory animals to microbial Infections*' 
Chrlstovao, In 1957# showed that Deceresol-OT 
and sodium lauryl sulfate enhanced the path- 
ogenlclty of Shlgella dysenterlae, Shigella 
paradysenterlae, and Sal monel la typhosa (3*0.
A study by Amsterdam and Schnelerson compared 
the actions of b1 1e salts and the surface- 
active agents Naccosal A, Aerosol MA, Triton 
X-100, and Tween 80 to gastric mucin (35).
They used several different genera of 
bacteria and the fungus Candida Albicans. 
Amsterdam and Schnelerson found that sur­
factants Increased the susceptibility of 
mice to these microorganisms.
The effects of surface-active agents on animal 
tissues have been briefly studied. Goldhammer and McManus, 
1n an jn vivo study, found that 0.1 ml of certain sur­
factants, when placed on the surface of the liver and
- 9-
kldneys of rats and mice, caused the deaths of the major­
ity of the animals (36).
Nlsslm studied the actions of some surface-active 
agents on the gastrointestinal mucosa (37). He observed 
that small doses of cationic compounds killed laboratory 
mice. Hemorrhages at the pyloric portion of the Intestine, 
the duodenum, the jejunum, and the Ileum were seen.
Large doses of the anionic compound, sodium lauryl sul­
phate, given Intraperltoneal1y killed laboratory animals, 
but no pathologic abnormalities were observed. Non- 
Ionic compounds did not affect the laboratory mice.
Surface-active agents also affect phagocytic 
rates. In 1949# Berry eit a1_. (In an J[n vitro study) 
found that 5 of 52 surface-active agents doubled the number 
of bacteria Ingested per human neutrophlle compared to con­
trol values (38). They mentioned, however, that some 
surface-active agents depressed phagocytosis.
Another study by D1 Luzlo and Wooles 1n 1964 
showed that the phagocytic activity of the reticulo­
endothelial system Is depressed by methyl palmltate (39). 
Purpose of Research
Generally man, not unlike the laboratory mouse,
Is somewhat resistant to Candida albicans Infections.
- 10-
However, If the condition of the host Is Impaired or 
altered, he Is more susceptible to candidiasis. For 
example, 1f man receives extensive antibiotic therapy, 
candidiasis might develop (40). People suffering from 
malnutrition, diabetes, or Idiopathic hypoparathyroidism 
are also susceptible to candidiasis (41, 42, 43).
It Is not surprising, therefore, that man has 
tried to Increase the susceptibility of mice to Candida 
albicans by pre-treat1ng mice. There are several reasons 
that make an Increased mortality rate 1n mice desirable!
(a) Increased death rates enable one to do 
chemotherapeutic studies In a shorter time 
period.
(b) Treated mice may be used as a diagnostic 
tool. Hopefully the treated mouse will 
show typical pathologic symptoms sooner 
than untreated mice.
(c) Mice are cheaper than other laboratory animals 
and also utilize less space.
f
Since some earlier work showed that certain sur­
face-active agents increased the susceptibility of mice 
to bacteria, and because surface-active agents were much 
easier to manipulate than gastric mucin and roentgen
- 11-
radlatlon, an attempt was made to evaluate the action of 
certain non-ionic surface-active agents on the suscept­
ibility of white Swiss mice to Candida albicans.
The effects of Mulsor 22k, Pluronlc L62, PIurafac 
B26 and Polyethylene Glycol kOO Mono Laurate were deter­
mined on female Swiss mice. Also LD50's were ascertained 
for Candida albicans and for various Candida alblcans- 
surface-actlve agent combinations when Injected Intraperl- 
toneally Into these animals.
Other studies Included heart blood cultures of 
Infected mice, histological studies of mouse kidneys, and 
1n vivo studies of the effects of surface-active agents 
on Intraperltoneal leukocytes. A non-pathogen, Candida 
utl1 1s, was also Injected with surface-active agents to 
act as a system control.
The above experiments allowed the author to sug­
gest the mechanism of surface-active action.
MATERIALS
Organisms
A strain of Candida albicans was secured from the 
Department of Microbiology stock culture collection and 
was maintained on Sabouraud dextrose agar slants at room 
temperature (2^°C). The organism was transferred monthly 
to insure viable cells for the experiments. The culture 
was checked periodically by the method of Martin to 
determine culture purity (MO.
A strain of Candida util 1s also was obtained from 
the departmental collection and was used In a series of 
experiments. This culture was maintained as outlined 
above.
Media
All cultures were maintained on Bacto-Sabouraud 
dextrose agar purchased from Difco Laboratories, Detroit, 
Michigan. This medium contained 10 grams of neopeptone,
40 grams of dextrose, and 15 grams of agar per liter.
Surfactant-Sabouraud liquid media were also used 
for a series of experiments. Ninety-nine samples of 
Sabouraud liquid medium were autoclaved at 15 pounds pres-
- 12-
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sure for 15 minutes. The following quantities of surfact­
ants were added; 0.3 ml of Polyethylene Glycol 400 Mono 
Laurate and 0.2 ml of Mulsor 224.
Sabouraud liquid medium was used throughout the 
project to grow large numbers of Candida organisms. This 
medium consisted of 10 grams neopeptone and 20 grams dex­
trose per liter. One hundred ml samples of the broth were 
prepared In 500 ml Erlenmeyer flasks and were sterilized 
by autoclaving for 15 minutes at 121°C.
Other media were used to constantly Identify our 
culture of Candida albicans. These Included 1 per cent 
glucose, maltose, sucrose, and lactose broths with phenol 
red Indicators, blood agar plates, and corn meal agar 
plates.
Surface-Active Agents
Four non-Ionic surface-active agents were used:
(a) Mulsor 224--composed of long chain fatty acid esters 
of polyethylene glycol (Synthetic Chemicals, Inc., Paterson, 
Hew Jersey), (b) Polyethylene Glycol 400 Mono Laurate— com­
posed of a monoester of polyethylene glycol 400 and 1 auric 
acid (G1yco Products Co., Brooklyn, New York), (c) Pluronlc 
L62— a condensate of ethylene oxide with a hydrophobic 
base formed by condensing propylene oxide with propylene
- 14-
glycol (Wyandotte Chemicals Corp., Wyandotte, Michigan), 
and (d) Plurafac B26— an oxyethylated straight chain 
alcohol (Wyandotte Chemicals Corp., Wyandotte, Michigan).
All of the surface-active agents were 100 per 
cent concentrated.
Mice
Five-week old female Swiss mice were obtained 
periodically from Gopher State Cavlary, St. Paul, Minnesota. 
These mice weighed between 20 and 24 grams. Female mice, 
which were used for preliminary experiments, were also ob­
tained from the Biochemistry Animal Quarters at the Univer­
sity of North Dakota.
Needles and Syringes
Throughout the research, sterile non-pyrogen1c 2.5 
ml disposable syringes and sterile, disposable 25 gauge 
needles served for the Injection experiments (Becton, 
Dickinson and Company, Rutherford, New Jersey).
Non-Pyrogenlc Saline
Sterile, non-pyrogenlc 0.9 per cent saline was 
used In several experiments. This was obtained from 
Baxter Laboratories, Inc., Morton Grove, Illinois.
METHODS
Effect of Surface-Active Agents
Initially, the effects of Polyethylene Glycol 
kOO Mono Laurate, Mulsor 22k, Pluronlc L62, and Plurafac 
B26 were determined on white Swiss mice. Surfactant 
concentrations of 0.2 per cent, 0.5 per cent, 0.75 per 
cent, 1.0 per cent, 2.0 per cent, and 20.0 per cent 
were prepared and 0.5 ml portion of the solutions were 
Injected Intraperltoneal1y.
The solutions were prepared as follows: A 1.0 
per cent concentration was prepared by adding 0.1 ml of 
surfactant to 9.9 ml of 0.85 per cent saline. Other 
solutions were prepared 1n an analogous manner.
The mice were observed dally to determine the 
lethality of the surfactants. Macroscopic observation 
of the peritoneal cavities followed.
Characteristics of Candida albicans
A culture that had the following characteristics 
was considered to be Candida albicans: (a) no surface 
growth on Sabouraud acid broth, (b) typical, uniform, 
large, round, grayish colonies on blood agar streaked 
from Sabouraud broth and Incubated for 10 days at 37°C*
- 15-
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(c) fermentation of glucose and maltose with acid and gas, 
formation of acid In sucrose, and no fermentation of lac­
tose In 1 .0 per cent carbohydrate broths Incubated for 
10 days at 37°C, and (d) typical branching tree-like 
mycelium with chlamydospores 1n corn meal agar plates In­
cubated for 10 days at 37°C.
Preparation of the Organisms
Four days before an experiment was scheduled an 
inoculum of Candida albicans was placed In a flask of 
Sabouraud liquid medium. The cells were allowed to grow 
at room temperature (2^°C) for kS hours. The broth cul­
tures were then placed In sterile tubes and centrifuged 
at 3000 rpm for 15 minutes. The supernate was removed, 
and the organisms were resuspended In 0.85 per cent saline. 
These were centrifuged again and the saline was removed.
A total of three saline washings was run (unless otherwise 
stated). The organisms were finally resuspended In 0.85 
per cent saline.
Pour plate dilutions of the cell suspensions were 
made. Two days later the dilutions showing 30-30 colonies 
per plate were counted on a Quebec counter. The number 
of organisms present per ml 1n the original suspension 
was thus determined.
The proper dilution of organisms was made for 
each experiment. Pour plates were once again prepared
- 17-
to determine 1f the proper dilution had been made.
General Procedure
A 10 ml surfactant-organism solution was usually 
prepared. Preliminary calculations showed the volume of 
organisms that would result In the desired number of 
organisms per ml when diluted up to 10 ml. The remainder 
of the 10 ml volume was composed of 0.85 per cent saline 
and surface-active agents.
Firstly, the desired amount of saline and surfactant 
was placed 1n a sterile vial; secondly, the necessary volume 
of cells was added to the mixture. (Preliminary work 
showed that If organisms were added to undiluted surfactants, 
death of many organisms resulted). A 1.0 ml sample was 
removed for plate counts* portions of the remainder of 
the mixture were Injected Into white Swiss mice. A sep­
arate 2.5 ml syringe was used for each organism-surfactant 
combination, and also a new sterile needle was used for 
each animal.
The caged mice (5 mice per cage) were provided 
with laboratory chow and water dally. Upon the death of 
the mice (especially those mice that died within kQ hours 
after Injection) the peritoneal cavity was observed macro­
scop leal 1y to determine If death was due to hemorrhage as
a result of Injection.
The mice were observed dally for a 30 day period, 
at which time all surviving mice were destroyed.
Determination of LD50
The classical method of Reed and Muench was used 
to determine the LD50's (45). With this method It was 
assumed that an animal alive at a given dilution (either 
of surfactant or Candida albicans, depending on the ex­
periment) would have lived at a higher dilution* and con­
versely, an animal dead at a given dilution would have 
died at a lower one. An example of the calculations follows:
-18-
Total Per cent
0 1lutlon Al Ive Dead* Alive Dead* Mortality
1 :2 0 5 0 12 100
1:4 1 4 1 7 88
1:8 3 2 4 3 43
1 :16 4 1 8 1 12
1:32 5 0 13 0 0
*30 days
FORMULA FOR CALCULATION PER CENT ENDPOINT:
% dead above 50% - 50% * Proportional
%^ieaH,_aFove^0%^^~^a3~ 15eTCTirs^~ 01 stance
- 19-
Logarithm of k (lower dilution) 
.73 (proportional distance)
0.602
X logarithm of 2 (dll 
Sum (logarithm of endpoint)
lutlon factor) 0.220
0.822
The anti logarithm of 0.822 Is 6.63, therefore the LD50 
dilution Is 1 :6.63.
LD50 of Varying Amounts of Surfactants Plus a Constant 
Amount of Candida albicans
Dilutions of 1.0 per cent, 0.75 per cent, 0.5 per 
cent, and 0.25 per cent of the four previously mentioned 
surfactants were prepared. These solutions also contained 
k X 10? organisms per ml. One-half ml of each dilution 
of surfactant-Candida albicans mixture was Injected 1n- 
traperltoneal1y Into each of 10 mice. Saline and Candida 
albicans controls were also Included. The mice were ob­
served for 30 days at which time the LD50's were deter- 
mlned.
LD50's of Candida albicans Combined With 1 Per Cent Surfactant 
Solutlons
One per cent surfactant solutions containing vary­
ing numbers of Candida albicans were prepared as outlined
above. Each mouse received 0.5 ml of a surfactant-Candida 
albicans preparation intraperltoneally. A total of 10 
mice for each surfactant-organism mixture was used. The 
mice were observed for a 30 day period, and the LDSO's 
were calculated.
Experimental Trials of Non-pathogenlc Candida util 1s and 
Surfactants on Mice
'
The effects of 2 surfactant-Candlda ut111s combin­
ations on mice were determined. One per cent solutions 
of Plurafac B26 containing k X 10? Candida ut111s organisms 
per ml and Polyethylene Glycol kOO Mono Laurate contain­
ing k X 107 Candida ut111s organisms per ml were prepared. 
One-half ml samples of each combination were Injected In­
traperltoneally into white Swiss mice. The mice were 
checked for 30 days to determine 1f the solutions were 
Infectious.
In vivo Leukocytic Response to a Candida alblcans-Surfactant 
Combinati on
Candida albicans organisms were washed 3 times with 
0.85 per cent saline as above, and then were washed 3 times 
with sterile, non-pyrogenlc saline (Baxter Laboratories 
Inc., Morton Grove, Illinois). Candida albicans solutions 
were placed In sterile bottles that had been washed In a 
Trylon Ultrasonic Cleaner (A.S. Aloe Co., Minneapolis,
- 20-
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Mlnnesota) and then rinsed 3 times In distilled water,
3 times In double-distilled water, and 3 times In non- 
pyrogenlc saline.
The technique of Fruhman was modified for this 
study (46). Control mice received 0.5 ml of sterile, 
non-pyrogenic 0.9 per cent saline 1ntraper1tonea1 1y.
Three other 0.5 ml solutions were Injected: (a) 2 X 10^ 
Candida albicans, (b) 2 X 107 Candida albicans plus 1 per 
cent Plurafac B26, and (c) 2 X 10? Candida albicans plus 
1 per cent Polyethylene Glycol 400 Mono Laurate. After 
3 and 5 hours, mice were sacrificed and 0.5 ml of heparin­
ized 0.85 per cent saline was Injected Intraperltoneal1y. 
This was done because after 3 and 5 hours most of the ori­
ginal 0.5 ml of saline was absorbed. The abdomen was 
massaged gently for 1 minute. An Incision was made In 
the peritoneal cavity and the fluid was collected with 
a sterile syringe and needle. The volumes of the collected 
fluids were measured, and white blood cell counts were 
determined with a Neubauer hemocytometer. Differential 
counts were obtained after staining with Wright's solu­
tions. Percentages and total numbers of lymphocytes—  
monocytes, neutrophlles, and eoslnophlles were thus 
obtained.
-22-
Experlmental Trials of Candida albicans and Candida alblcans- 
Surfactant Mixtures of Certain Mouse Tissues
Solutions of 1.0 per cent Plurafac B26 Candida 
albicans (4 X 10? organ1sms/m1) and of Candida albicans 
(4 X 10? organlsms/ml) were Injected Into mice. After 
death of the animals or after 24 hours (whichever came 
first), the kidneys and the pancreas were removed and 
placed In formalin. No other tissues were studied as 
others had reported that the before-mentioned organs were 
the foci of Infection (k7). Periodic acid - Schlff and 
methenamlne silver stains of the tissues were prepared 
by the UNO Pathology Laboratory. Micro-photographs 
were made of representative tissue sections.
An effort was also made to Isolate Candida albicans 
from the blood of infected animals. Blood was removed 
from the mice by snipping the tall. Samples were obtained 
at 0, 2, 4, 8 and 2k hours from mice Injected with 2 X 107 
Candida albicans. Heart blood cultures were prepared 
from mice that died within 24 hours or from the mice sacri­
ficed at the end of 24 hours.
Tall-blood cultures were also prepared from mice 
injected with 6.7 X 10® Candida albicans. At the time 
of death of the mice (usually within 24 hours), heart
-23-
blood cultures were prepared, and the kidneys and pancreas 
were removed for tissue studies as before.
Experimental Trials of Candida albicans Grown In Surfactant
f
Culture Media Mixtures on wHlte Swiss Mice
Marwln reported that Candida albicans organisms 
grew faster In media containing 0.3 per cent Polyethylene
s
Glycol A00 Mono Laurate and 0.2 per cent Mulsor 22k
than In control media (kQ)i therefore, attempts to deter-
’
mine If cells grown 1n the before-mentioned media would 
be more pathogenic for white Swiss mice than Candida 
albicans alone were undertaken. Candida albicans organ­
isms were grown In 99 ml samples of Sabouraud liquid 
medium containing the desired surfactant. After kB hours 
the cells were harvested and washed 3 times with O.85 
per cent saline. The cells were resuspended In O .85 per 
cent saline, and plate counts were made.
Various dilutions of the surfactant-grown organisms 
were injected Into mice to determine the LD50’s. The 
LD50 of Candida albicans grown without surfactants was 
also included ih the experiments.
RESULTS
Examination of Table 1 shows that non-Ionic sur- 
face-active agents are not uniformly lethal for female 
white Swiss mice. One observes that the level of toxi­
city for Polyethylene Glycol LOO Mono Laurate and Plura- 
fac B26 1s between 1.0 and 2.0 per cent, with Plurafac 
B26 being the more toxic of the two surfactants. The 
toxic levels of Mulsor 22L and Pluronlc L62 were not 
determined. Autopsled animals revealed no pathologic 
abnormalities; however, a large amount of fluid gathered 
in the peritoneal cavity following the Intraperltoneal 
Injections of the surfactants. To Insure that deaths 1n 
later experiments would not be due to surfactant action, 
concentrations of 1.0 per cent or less were used In the
remaining experiments.
The Candida albicans culture was checked period­
ically by methods described above. Invariably, the cul­
ture produced acid and gas fram glucose and maltose, pro­
duced acid from sucrose, and failed to ferment lactose. 
The culture also failed to grow on the surface of Sabour- 
aud liquid media, formed grey colonies on blood agar, and 
formed chlamydospores In corn meal agar plates.
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Table 1. - Lethality of various concentrations of surfactants Injected
intraperltoneally In 0.5 ml volumes




Glycol M)0 Mulsor 22^ Pluronlc L62 Plurafac B 26
Mono Laurate
0.2% 0 0 0 0
1.0% 0 0 0 0
2.0% 3X 0 0 7y
Observation period - 30 days 
*D1ed within 2 days 
M)1ed within 3 days
-2 6 -
The pathogenicity of the culture, which remained 
stable throughout the project, was checked by determining 
LD50‘s. The results of Tables 2 and 3 show that the LD50 
is near 10® organisms. Calculation from these data yield­
ed LD50's of 7 X 10? for Table 2 and 8.4 X 10? for Table 
3. A combination of the data gave an L050 of Candida 
albicans of 7.7 X 107 (Table 16).
A study of Tables 4-9 and 10-15 shows that sur­
factants Increase the susceptibility of mice to Candida 
albicans. Tables 4-9 condense an attempt to determine 
the effect of various amounts of each surfactant with a 
constant amount of Candida albicans. They show that ap- 
parently Plurafac 826 Is the most effective susceptibility 
enhancing agent and Polyethylene Glycol 400 Mono Laurate 
the least effective. Mulsor 224 and Pluronlc L62 are 
Intermediate In effect. These data are presented as the 
L050 of each surfactant (Tattle 17). The percentage of 
surfactant plus 2 X 107 Candida albicans that kills 50 
per cent of white Swiss mice are 0.33 per cent Plurafac 
826, 0.84 per cent Polyethylene Glycol 400 Mono Laurate, 
0.64 per cent Mulsor 224 and 0.61 per cent Pluronlc L62.
The attempts to characterize the actions of the 
surfactants are summarized in Tables 10-15. Here the
Table 2. - Fatalities of female Swiss mice injected with varying amounts of








Time of Death 
Days Weeks
1 1  3 1* 5 6 7 1  $ h
Total Dead at 30 Days
10 5 X 108 0.5 rat 8 2 10
8
10 10 0.5 ral 1 2 2 1 1 7
10 5 X 107 0.5 ml 1 2 1
10 107 0.5 ml 0
10 • 0.5 ml 0
-L
Z-
Table 3. - Fatalities of female Swiss mice Injected with varying amounts of








Time of Death 
Days Weeks 
T ? y %  5 S I 2 3 k
Total Dead at 30 Days
10 5 X 108 0.5 ml 6 2 1 1 10
10 108 0.5 ml 3 1 1 1 6
10 5 X 107 0.5 ml 1 1 2
10 ,07 0.5 ml 0
10 m 0.5 ml 0
Table k. - Fatalities of female Swiss mice injected with Candida albicans and
varying percentages of PTurafac B26 - Series I
No. No. of Volume Time of Death Total Dead











0.5 ml 10 10
0.75% 10 2 X 107 0.5 ml 7 2 1 10
0.50% 10 2 X 107 0.5 ml 6 3 9
0.25% 10 2 X mm* o 0.5 ml 1 3 k
1.0% 10 mm mm 0.5 ml 0
Saline Control 10 0.5 ml 0
Table 5 . - Fatalities of female Swiss mice injected with Candida albicans and
varying percentages of Plurafac 8 2 6 - Series II
No. No. of Volume Time of Death Total Dead









1.0% 10 2 X 107 0.5 ml 10 10
0.75% 10 2 X 0 "
•4
0.5 ml 8 1 1 10
0.50% 10 2 X O 0.5 ml 5 1 1 8
0.25% 10 2 X 107 0.5 ml 3 1 4
1.0% 10 - - 0.5 ml 0
Saline Control 10 0.5 ml 0
Table 6. - Fatalities of female Swiss mice injected with Candida albicans and
varying percentages of Polyethylene Glycol 400 Mono Laurate - Series I
Polyethylene No. No. of Volume Time of Death Total Dead
Glycol 400 Mice Organisms Injected Days Weeks at 30 Days
Mono Laurate Injected 1 2 3 4 5 6 7  2 3 4
1.0% 10 2 X 107 0.5 ml 4 4 1 9
0.75% 10 2 X 107 0.5 ml 2 2
0.50% 10 2 X 107 0.5 ml ....................  0
0.25% 10 2 X 107 0.5 ml ....... ............  0
1. 0% 10 - -  0 .5  ml ...................................  0
Saline Control 10 —  0.5 ml - - - - - - -  _ _ _ o
Table 7. - Fatalities of female Swiss mice injected with Candida albicans and
varying percentages of Polyethylene Glycol bOO Mono Laurate - Series 1I
Polyethylene 
Glycol bOO
No. No. of Vol ume Time of Death Total Dead
Mice Organisms
Injected
Injected Days Weeks at 30 Days
Mono Laurate 1.2 T V  '5 6 7 ? 3 b
1.0% 10 2 X 107 0.5 ml 8 1 1 10 1
0.75% 10 2 X 107 0.5 ml 1 1 1 3
N>1
0.50% 10 2 X 107 0.5 ml 0
0.25% 10 2 X 107 0.5 ml 0
1.0% 10 «• mm 0.5 ml 0
Saline Control 10 0.5 ml 0
Table 8 . - Fatalities of female Swiss mice Injected with Candida albicans and
varying percentages of Mulsor 224
No. No. of Volume Time of Death Total Dead
Mulsor 224 Mice Organisms Injected Pays Weeks at 30 Days
Injected T " T y T 5 ^ " 7  2 3 4
1.0* 10 2 X 107 0.5 ml 6 1 1 1  9
0.75% 10 2 X 107 0.5 ml 8 8
0.50% 10 2 X 107 0.5 ml 1 1 2
0.25% 10 2 X 107 0.5 ml ...................  0
1.0% 10 —  0.5 mi ...................  0
Saline Control 10 —  0.5 ml - - - - - - -  - - _ 0
Table 9. - Fatalities of female Swiss mice injected with Candida albicans and
varying percentages of Pluronic L62
Ho. No. of Volume Time of Death Total Dead
Pluronic L62 Mice Organisms Injected ... ""Pays' at 30 Days
Injected 1 2 3 * 5 6 7  2 3 h
1.0% 10 2 X 107 0.5 ml 8 1 9
0.75% 10 2 X 107 0.5 ml 2 3 5
0.50% 10 2 X 107 0.5 ml 2 1 2 1 6
0.25% 10 2 X 107 0.5 ml - .................. 0
1.0% 10 —  0.5 ml ...................  0
Saline Control 10 —  0.5 ml - - - - - - -  - - - 0
Table 10. - Fatalities of female Swiss mice Injected with 1.0 per cent Plurafac
826 and varying numbers of Candida albicans - Series I
No. No. of Volume Time of Death Total Dead





TT'5 "6 7 i i  h
at 30 Days
1.0% 10 ,o8 0.5 ml 10 10
1.0% 10 107 0.5 ml 9 1 10
1.0% 10 ,o6 0.5 ml 3 1 k
1.0% 10 !05 0.5 ml 2 1 3
1.0% 10 10** 0.5 ml a? 0
1.0% 10 a» 0.5 ml 0
Saline Control 10 m 0.5 ml 0
Table 11. - Fatalities of female Swiss mice Injected with 1.0 per cent Plurafac









Time of Death 
Days Weeks
t i 3 k ? 5 f " H I
Total Dead 
at 30 Days
1.0% 10 ,o8 0.5 ml 10 10
1.0% 10 107 0.5 ml 10 10
1.0% 10 io6 0.5 ml 2 2
1.0% 10 ID? 0.5 ml 2 1 1 k
1.0% 10 to5 0.5 ml 0
1.0% 10 10** 0.5 ml 0
1.0% 10 - 0.5 ml 0
Saline Control 10 tm 0.5 ml 0
Table 12. - Fatalities of female Swiss mice Injected with 1.0 per cent Poly
ethylene Glycol 400 Mono Laurate and varying numbers
of Candida albicans - Series I
Polyethylene Ho. No. of Volume Time of Death Total Dead
Glycol 400 Mice Organisms Injected ______Days Weeks at 30 Days










10 to7 0.5 ml
10 106 0.5 ml




10 - 0.5 ml
10 0.5 ml
9 1 10
2 4 2 8
1 1 1  3
0
.... ..............  0
...................  0
Saline Control 0
Polyethylene No. No. of Volume _____Time of Death Total Dead
Glycol *f00 . Mice Organisms Injected Days Weeks at 30 Days
Mono Laurate Injected 1 2 3 ** 5 & 7 2 % 4
1.0% 10 108 0.5 ml 10 10
1.0% 10 107 0.5 ml ^ 1 1 1 7
6
1.0% 10 10 0.5 ml 1 1 2
1.0% 10 105 0.5 ml ......... .. o
L
1.0% 10 10 0.5 ml ..................  0
1.0% 10 - 0.5 ml ..................  0
Table 13. - Fatalities of female Swiss mice Injected with 1.0 per cent Poly­
ethylene Glycol kOO Mono Laurate and varying numbers
of Candida albicans - Series II
Saline Control 10 - 0.5 ml - - - - - - - - - -  0
No. No. of Volime Time of Week Total Dead
Pluronic L62 Mice Orqanlsms Injected Bays Weeks at 30 Days
Injected 1 I T V  5 T T T J 1
1.0% 10 108 0.5 ml 7 3 10
1.0% 10 107 0.5 ml 1 9 10
6
1.0% 10 10 0.5 ml 1 1
1.0% 10 105 0.5 ml ....................  0
1.0% 10 10" 0.5 ml ....................  0
1.0% 10 - 0.5 ml .......... .... - - 0
Table \k. - Fatalities of female Swiss mice injected with 1.0 per cent Pluronic
L62 and varying numbers of Candida albicans
Saline Control 10 - 0.5 ml - - - - - - - - - -  0
Table 15. - Fatalities of female Swiss mice Injected with 1.0 per cent Mulsor
224 and varying numbers of Candida albicans
No. No. of Volume Time of Death Total Dead
Mulsor 224 Mice Organisms Injected bays Weeks at 30 Days
Injected TTTT"5"A'T" T  T~4
1.0% 10 108 0.5 ml 4 6 10
1.0% 10 107 0.5 ml 8 2 10
6
1.0% 10 10 0.5 ml 1 1 2
1.0% 10 105 0.5 ml .................... 0
1.0% 10 104 0.5 ml ....................  0
1.0% 10 - 0.5 ml - ..................  0
Saline Control 10 - 0.5 ml - - - - - - -  - - -
Table 16. - Summary of Tables 2, 3* and 10 —  15. LD50's of 1.0 per 
cent surfactants combined with Candida albicans 
dilutions of 10*, 105, 10<>, 10?, and 108






















2.k X 106 
3.2 X 106
Table 17. - Suninary of Tables 4 —  9. LD50*s of 2 X 107 Candida 
albicans combined with surfactant dilutions of 0.25 per cent,
0.5 per cent, 0.75 per cent, and 1.0 per cent
Mi xture Mo. Mice/Oilution LD50
(Surfactant concentration)
2 X 10? C. albicans 
+ PluraTac B26
20 0.33%
2 X 10? C. albicans 
+ Poly. Glycol
20 0.84%
2 X 107 C. albicans 
+ Pturonic L65
10 0.61%
2 X 10? C. albicans 
♦ Mulsor 224
10 0.64%
percentage of surfactant was a constant 1.0 per cent, from 
the L050 data of Table 16, we again see that surfactants 
Increase mouse susceptibility to Candida albicans. One 
observes that all of the surfactants decrease the LD50 by 
at least a factor of 20. There also appears to be a leth­
ality enhancing variation among the surfactants but the 
contrast Is not as definite as the percentages of surfact­
ants.
One can also observe a trend In the death rates 
by perusing Tables 2-15. Overwhelming numbers of Candida 
albicans alone killed most of the mice within 3 days, but 
lower numbers of organisms produced a more chronic Infec­
tion and deaths were distributed over a four week period 
(Tables 2, 3).
Analogous results were obtained when surfactants 
were added. The majority of mice that died expired within 
3 days after Injection, but at lower concentrations of sur­
factants or Candlda a1bicans. Deaths were scattered over 
the initially stated observation period (Tables 4-15).
Often mice Injected with 5 X 107 and 10® Candida 
albicans that survived the 30 day test period were ema­
ciated at the completion of the experiment. Contrasted 
to this, mice surviving the surfactant-Candida albicans
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experiments appeared to be In fine health.
Usually the animals Injected with 1.0 per cent 
surfactants or surfactant-Candlda albicans were very In­
active after Injection, and they remained so for 12-18 
hours. Mice Injected with less than 1.0 per cent sur­
factants remained normally active.
Another experiment wss conducted to determine If 
pathogenic properties of Candida albicans were necessary 
to get fatalities 1n the mice. Therefore, mixtures of 1.0 
per cent surfactants and Candida util 1 s (4 X 10^ organisms/ 
ml) were Injected Intraperl tones11y Into female white Swiss 
mice. These mice uniformly survived these mixtures.
To determine If Candida albicans grown In sur- 
factant-Sabouraud media were more pathogenic, another 
experiment was run. The results are reported In Tables 
18 and 19. The LD50's of cells grown 1n Mulsor 224 
(5.1 X 107) and of cells grown in Polyethylene Glycol 
400 Mono Laurate (5.6 X 107) are quite similar to those 
of Candida albicans alone (Table 16).
Total leukocyte counts are presented In Tables 
20 and 21. Perhaps the most notable feature of these 
tables Is the number of leukocytes present when 2 X 1o7 
Candida organisms suspended In Plurafac B26 are Injected.
Table 18. - Fatalities of female Swiss mice injected with varying 










T T T T 1
of Oeath 
rs Weeks
i 6 1 2 1 k
Total Oead 
at 30 Days
10 108 0.5 rat 2 1 1 2 1 7
10 107 0.5 ml 0
10 106 0.5 tn1 0
10 105 0* 5 ml 0
10 10* 0.5 ml 0
10 0.5 ml 0
Tabic 19. - Fatalities of female Swiss mice injected with varying 
numbers of Candida albicans grown in Polyethylene Glycol ^00 








Time of Death 
Days Weeksm  r i”6’TT  ys
Total Dead 
at 30 Days
10 108 0.5 ml 1 2 1 1 1 6
10 107 0.5 ml 1 1
10 106 0.5 ml 0
10 105 0.5 ml 0
10 10^ 0.5 ml 0
10 0.5 ml 0
Table 20. - Leukocyte response In mice 3 hours afer Intraperltoneal Injections












0 0 0.30cc 13,300 3,990,000
0 0 0.29cc 9,750 2,827,500
0 0 0.25cc 14,700 3,675,000
Phys. saline 3 0.35cc 12,000 4,200,000
Phys. saline 3 0.4lcc 12,100 4,961,000
Phys. saline 3 0.32cc 15,450 4,944,000
2 X 10? C. albicans 3 0.68cc 17,600 1 1 ,968,000
7
2 X 10 C. albicans 3 0.70cc 19,750 13,825,000
2 X 10^ C. albicans 3 0.40cc 25,450 10,180,000
ontinued___













2 X 10? C. albicans 3 0.90cc 3,050 2,71*5,000
♦ 1.05TP1 urafac 826 
2 X 107 C. albicans 3 1.1Occ 3,550 3,905,000
+ 1.0% PIurafac 826
2 X 10? C. albicans 
+ 1.0% Pjurafac Bfc6
3 1.1Occ 1,200 1,320,000
Table 21. - Leukocyte response In mice 5 hours after intraperitoneal injection of













Phys. saline 5 0.20cc 17,950 3,590,000
Phys. saline 5 0.23cc 16, W O 3,790,000
Phys. saline 5 0.25cc 16,600 4,150,000
2 X 107 C. albicans 5 0.50cc 22 M O 11,225,000
2 X 107 C. albicans 5 0.45cc 19,600 8,820,000

















2 X 10* C. albicans 
+ 1.0% Flurafac B26
5 1.20cc 10,000 12,000,000
2 X 10^ C. albicans 
+ PIuraTac 1$26
5 0.90cc 10,750 9,675,000
2 X 107 C. albicans 
♦ 1.0% PI uraf*ac B2&
5 0.70cc 10,750 7,525,000
At 3 hours these leukocyte counts are lower than physio­
logical saline counts; but at 5 hours these counts are 
very similar to those obtained from the Injection of 2 X 10^ 
Candida albicans alone.
Also, surface-active agents Increase the volume 
of fluids 1n the peritoneal cavity.
Differential leukocyte counts were made at 3 and 
5 hours. These counts are recorded 1n Table 22. As with 
Fruhman's work, lymphocytes and monocytes were grouped 
together because transitional forms and the Wright stain­
ing technique made differentiation difficult (49). Table 
22 shows that non-pyrogenlc saline does not stimulate 
the influx of neutrophlles -- the percentage remained 
near 2 per cent. An Interesting fact, however, was that 
Candida alblcans-Plurafac B26 and Candida albicans alone 
greatly Increased the percentage of neutrophlles com­
pared to eoslnophlles and lymphocytes - monocytes.
Another Interesting observation was made upon 
examination of the tissue slides. The majority of 
Candida albicans organisms present In the peritoneal 
fluid at 3 and 5 hours were mycelial forms. Occasion­
ally hyphal forms of the fungus were seen within leuko­
cytes, but the scarcity of leukocytes containing Candida
- 51-
Table 22. - Leukocytes recovered from intraperltoneal cavities of mice injected with












0 0 3 300 98% 1% 1%
Phys. saline 3 3 300 98% 0 2%
2 X 107 C. albicans 3 3 300 52% 2% 46%
2 X 
♦1.
107 C. albicans 
,0% PTurafac B26
3 3 300 32% 2% 66%
Phys. saline 5 3 300 93% 0 2%
2 X 107 C. albicans 5 3 300 43% 3% 54%
2 X 
♦
107 C. albicans 
1.0% P1urafac B26
5 3 300 33% 2% 65%
alblcans prevented an opsonic Index study.
Representative tissue sections stained with perlodl 
acld-Schiff solutions are pictured on Plates 1-8. Plates 
1 and 2 show normal sections of the kidney and pancreas, 
respectively. Tissue sections of 10 animals Injected In­
traperl toneal 1y with 2 X 107 Candida albicans suspended 
In 1.0 per cent Plurafac 826 Invariably showed Infections 
of the pancreas but not of the kidney. Plate 3 shows 
the organisms Invading the cellular structure of the pan­
creas from the periphery Inward, while Plate k shows a 
complete destruction of adnl with many hyphal elements 
present.
Sections of the pancreas and kidneys of mice that 
received only 2 X 10^ Candida albicans did not show In­
fections in these organs. However, Candida organisms 
were observed In connective tissue near the pancreas 
(Plate 5).
Mice that received an overwhelming number of
a
Candida albicans (6.7 X 10 ) died within 2b hours. Sec­
tions showed massive Infection of the pancreas and kidneys 
(Plates 6, 7, 8). The kidney usually contained several 
foci of Infection from which hyphal strands radiated.










Table 23. - Invasion of pancreas and kidneys of white Swiss mice by Candida
albicans
Substance No. Time No. Pancreas Invaded Kidneys Invaded
Injected Mice Trial Dead
2 X 107 C. albicans 10 2k hr 0 0 0
2 X 107 C. albicans 
+ 1.0% Plurafac 826
10 2k hr 10 10 0
6.7 X 10® C. albicans 10 2^ hr 10 10 10
Interesting observation was that there were no Infections
of the kidneys of female white Swiss mice injected with
2 X 10^ Candida albicans plus 1.0 per cent Plurafac B26,
but there were Infections of the kidneys of mice Injected 
, . 8with 6.7 X 10 organisms.
Also mice that received 2 X 10^ Candida albicans 
plus 1.0 per cent Plurafac 826 had massive infections of 
the pancreas, but mice that received only 2 X 10? Candida 
albicans organisms did not have these Infections.
Results from the blood cultures from mice Injected 
with Candida alblcans plus Plurafac 826 were as follows*
(a) no Candida albicans organisms were Isolated from tail 
blood, (b) no Candide albicans organisms were Isolated 
from heart blood cultures either from mice that had died 
naturally, or from mice sacrificed at 2k hours.
No Candida organisms wera Isolated within 2k 
hours from mice Injected with 2 X 10? organisms, but 
Candida albicans were isolated from tell blood cultures
et 12 hours end from heart blood cultures of mice Inject-
8ed with 6.7 X 10 celts. This Is summarized 1n Table 2k.
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Table 2k, - Tall and heart blood cultures of Candida albicans and 
PIurafac 826 - Candida albicans mixtures
Positive Cultures per 10 Mice _____  «
Time 2 t 1q7 t. albicans* 2 X 10' 6.7 X t0°~












♦Observation period - 
at time of death
2k hours. Blood secured at 2k hours or
DISCUSSION
The most striking effect of Injecting a non-1etha1 
amount of surfactant (1.0 per cent) with a non-lethal num­
ber of Candida albicans (2 X 10^ organisms) was the death 
of nearly all of the test animals within 2 or 3 days. If 
the amount of surfactant was decreased, and the number of 
organisms remained constant, the death rate decreased.
These experiments showed that a smaller percentage of Plura- 
fac 826, compared to the other surfactants, was necessary 
to get a decreased LD50. The descending order of effective­
ness appeared to be Plurafac B26, Pluronlc L62, Mulsor 224, 
and Polyethylene Glycol 400 Mono Laurate.
Since It was found that the mortality rate was 
a function of the percentage of surfactant used, It was 
decided to use a high percentage of surfactant (1.0 per 
cent) to determine the LD50's of Candida albicans combined 
with the surfactants. When we compare the L050's of 1.0 
per cent surfactant - Candida albicans to Candida albicans 
(controls), we see that Polyethylene Glycol 400 Mono 
Laurate decreased the LD50 by a factor of 20, Pluronlc 
L62 by a factor of 26, Mulsor 224 by a factor of 30, and
-65-
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Plurafac B26 by a factor of 82. In both of these sets 
of experiments, then, Plurafac B26 most effectively low­
ers the L050 of Candida albicans to white Swiss mice.
Certain authors have shown that various agents 
Increase the susceptibility of mice to Candida albicans, 
but a few people have shown the actual decrease of the L050. 
Salvln showed that the LD50 of Candida albicans suspended 
In 2.5 per cent gastric mucin was 2.2 X 10? organisms, 
but he did not state the LD50 of Candida albicans alone 
(50).
Chrlstovao, however, stated that when Shigel la 
and Sa1mone!1a species were Injected Intraperltoneal1y 
with deceresol-OT and sodium lauryl sulphate, the LD50's 
were 7-200 times smaller than the controls (51). The 
variation was due to differences in organisms and sur­
factants tested.
Candida ut111s was used as a system control. 
Originally It was thought that possibly sheer numbers 
of organisms plus the before-mentioned surfactants could 
cause fatalities. We saw, however, that no fatalities 
occurred when Candida util 1s was Injected with surfact­
ants. Therefore, the pathogenicity of the organisms was 
also a factor In the mouse fatalities.
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SI nee the L050's of the organisms grown in sur- 
factant-Sabouraud media were not far removed from Candida 
albicans controls, it was decided not to pursue this part 
of the problem.
Fruhman reported that the peritoneal fluid in 
unstimulated rats contains less than 5 per cent neutro- 
phlfes (52). The remaining cells were mainly lympho­
cytes, monocytes and eosinphiles. He reported that 
sterile, non-pyrogenic saline failed to evoke a local 
neutrophile.
With this in mind. Tables 19, 20 and 21 show 
some interesting results. This work confirms that of 
Fruhman'sj that is, non-pyrogenic saline does not elicit 
a positive neutrophilic response. When an antigenic sub­
stance is injected (Candida albicans) we get a vast in­
crease 1n the number of leukocytes present, with a neutro­
philic percentage of U0-60. This constitutes a definite 
positive response. But when 1.0 per cent Plurafac B26 
is combined with the organisms, we find a decreased num­
ber of leukocytes at 3 hours. At 5 hours the number of 
leukocytes approaches that of the Candida albicans control.
In 1935 Hiller and Castles observed that poly­
morphonuclear leukocytes did not begin to accumulate un­
til after 3 hours following an intraper1toneal injection
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of gastric mucin and meningococci (53). Leukocyte num­
bers gradually Increased until 9 hours when they were 
abundant. Erlolo et a K  confirmed and enlarged upon the 
work of Miller and Castles (5*0. They observed a strong 
leukocyte response within 2.5-5 hours after injection with 
50,000 staphylococci. When gastric mucin was combined 
with the organisms, the leukocyte response was depressed. 
They observed, However, that when leukocytosis was already 
present, mucin did not Interfere with It and did not des­
troy leukocytes. An Important element of their work 
demonstrated that bacteria were rapidly destroyed when 
bacteria plus gastric mucin were Injected Intraperltoneally 
Into areas where leukocytosis already existed.
Does Plurafac B26 Initially Inhibit a positive 
neutrophilia response? Tables 19# 20 and 21 Indicate 
that Plurafac B26 does decrease the number of leukocytes. 
Two factors are Important: (a) the total number of 
leukocytes of mice receiving Plurafac B26 Is lower than 
that of the controls, and (b) the percentage of neutro­
phil es present at 3 hours 1s much greater than 5 per 
cent. These data then, seem to Indicate that a posi­
tive neutrophilic response occurs by 3 hours, but that
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possibly Plurafac B26 destroys the leukocytes once they 
enter the cavity. By 5 hours the leukocytic counts 
approach that of the Candida albicans control. Probably 
the surfactant Is diluted by this time and therefore Is 
not lysogenic. The action of Plurafac B26 appears to be 
distinct from gastric mucin.
A common consensus of previous workers was that 
deaths of mice due to candidiasis was a result of kidney 
Infections. Young showed that although many tissues may 
be Initially Infected with Candida albicans, the main foci 
of Infection were the kidneys and pancreas (55). He also 
stated that the pancreas was the route of Invasion of 
Candida albicans.
A study of tissue preparations revealed no In­
vasion of the kidney when 2 X 1 0 ?  Candida albicans or­
ganisms suspended In Plurafac B26 were Injected, although 
sections showed massive Invasion of the pancreas. Control 
animals (2 X 107 Candida albicans) did not show Infections 
of the pancreas or the kidneys after 2^ hours. Invasion 
of the connective tissue was the only sign of Candida 
Infection.
It 1s noteworthy that 6.7 X 10® organisms pro­
duced massive lesions In both kidneys and pancreas.
leslons of the kidney were observed throughout the medulla 
and cortex. Although Young (56) showed that Infection 
was via the pancreas* I also observed a direct mycelial 
Invasion of the kidney cortex.
These results demonstrate these facts: (a) 
mortality of mice Is due to Candida albicans Infections,
(b) Plurafac B26 Increases the rate of Infections of the 
pancreas, and (c) apparently early deaths of mice Inject­
ed with Plurafac B26 - Candida albicans are due to pan­
creatic lesions.
A result difficult to explain is the absence of
positive blood cultures, (either from tall blood or ^rom
heart blood) In animals Injected with 2 X 10? Candida
albicans suspended In Plurafac B26, and In animals 1n-
7
jected with 2 X 10 Candida albicans (controls). Two 
factors may be linked to these results: (a) the suddenness 
of death of animals Injected with Candida plus Plurafac 
826, and (b) too few Candida albicans In the controls.
Young reported that if A X 10^ Candida albicans 
were Injected intraperltoneal1y, 2k hours later the blood 
contained organisms (even If the culture was of low viru­
lence) (57). Mankowskl reported that blood from the tall 
vein contained Candida albicans 24 hours after Intraperl-
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toneal Injections (58). Since many of the mice Injected 
with Plurafac B26 - Candida albicans mixtures died with*,
mm  ■■ ih iiw ii.■■■■■■ « i  ■
1n 12-18 hours, possibly a systemic Infection did not 
occur and therefore blood cultures were negative.
The positive blood cultures resulting from In­
jection of 6.7 X 10® organisms also tends to show that 
a large number of organisms 1s necessary to get positive 
cultures by 2k hours and to suggest that Invasion of the 
kidney medulla may be via the bloodstream.
One wonders why the pancreas and the kidney are 
the foci of Infection. The pancreas may yield to In­
fection because of Its thin capsule. Certainly one may 
not eliminate the possibility that surfactants affect 
the capsular material of the pancreas thus allowing In­
fection to occur.
The reason that the kidney 1s often a focus of 
Candida albicans Infection 1s not completly understood. 
Louria believes the fungus grows 1n the renal tubular 
lumen and thus escapes host defenses (59)* Andriole 
and Hasenclever believe that complement may be of value 
In Inhibiting candidiasis (60). Beeson and Rowly have 
shown that an ant1complementary substance (to the fourth 
component) 1s present In the kidney (61). They believe
-71-
th1s substance 1s ammonia since this compound Inactivates 
the fourth component of complement. Most bacterial lesions 
are In the medulla which Is the principal site of ammonia 
formation. Perhaps the ammonia formed 1n the kidney In­
hibits complement action and allows the fungus Invasion 
to occur.
Apparently, certain surfactants Increase the 
susceptibility of mice to Candida albicans. The Initial 
Infection appears to be 1n the pancreas. Injection of 
Plurafac B26 - Candida albicans causes pancreatic lesions 
to appear and directly contributes to the mouse fatalities
(no kidney lesions were seen). Infection by large num-
8bers (6.7 X 10 ) of Candida albicans produces lesions 1n 
’>oth the kidney and pancreas. The mechanism of this In­
fection, however, is not understood.
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SUMMARY
The objectives of this thesis were twofoldj firstly, 
to determine If certain surfactants would increase mouse 
susceptibility to Candida albicans; and secondly, to deter­
mine the mechanism of action of surfactants.
Death rates were observed and LD50's were calcu­
lated for various diltuions of Candida albicans suspended 
in 1.0 per cent solutions of Plurafac 826, Polyethylene 
Glycol 400 Mono Laurate, Pluronic 162 and Mulsor 224.
The effects of various percentages of surfactants com-
7
blned with 2 X 10 Candida albicans organisms were also 
ascertained. Peritoneal leukocyte counts, differential 
counts, tissue sections, and blood cultures were done to 
help determine the action of surfactants with regard to 
inciting Infections.
The conclusions from these data are as follows*
(a) The non-ionic surfactants Plurafac 826,.
Polyethylene Glycol 400 Mono Laurate, Mulsor 
224, and Pluronic L62 increase mouse suscept­
ibility to Candida albicans.
(b) Plurafac B26 enhances mouse susceptibility 
to a greater degree than Polyethylene Glycol
-73-
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400 Mono Laurate. Pluronic L62 and Mulsor 
224 are intermediate in effect.
(c) Plurafac B26 apparently enhances the invasive­
ness of Candida albicans possibly by initial­
ly destroying leukocytes in the peritoneal 
cavity.
(d) Death of mice injected with Candida albicans 
suspended in Plurafac B26 may be due to des­
truction of the pancreas.
Because certain non-1onic surfactants have been 
shown to increase the infectivity rate of Candida albicans 
in mice, these surfactants might possibly be a diagnostic 
aid in the identification of Candida albicans.
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